Ogilvieʼs Syndrome from Disseminated Varicella-Zoster Infection and Infarcted Celiac Ganglia

Josep Nomdedéu(Centre de Recherche Jean Pierre Aubert), R Bordés(Hospital de Sant Pau), Rodrigo Martino(Universitat Autònoma de Barcelona), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), M.L. Rutllant(Hospital de Sant Pau), A Domingo-Albós(Clínica Rementería), R. Portorreal(Hospital de Sant Pau)
Journal of Clinical Gastroenterology
March 1, 1995
10.1097/00004836-199503000-00020
Cited by 51

Related Papers

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2015|740
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2022|718
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2023|538
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532